ANDA 74620, held by Hospira. Butorphanol Tartrate.
As of Nov 16, 2026, ANDA 74620 (Butorphanol Tartrate Preservative Free), held by Hospira, was first approved by FDA on Jan 22, 1997, with 2 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jan 22, 1997 | Original application | Approved | None posted |
| Butorphanol Tartrate Preservative Free1MG/ML · injectable;injection | Butorphanol Tartrate | Discontinued |
| Butorphanol Tartrate Preservative Free2MG/ML · injectable;injection | Butorphanol Tartrate | Discontinued |
| Oct 22, 1999 | Supplement 2Labeling | Approved | None posted |
| Nov 23, 1998 | Supplement 1Manufacturing | Approved | None posted |
| Jan 22, 1997 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters